Therapeutic drug classes carved out April 1, 2010

• Central Nervous System stimulants
• Barbiturates
• Sedative-hypnotic, non-barbiturate
• Anti-anxiety
• Monoamine oxidase inhibitors (MAOIs)
• Antidepressants
• Antidepressant combinations
• Anti-mania
• Antidepressants
• Antianxiety
• Sedative-hypnotics, non-barbiturates
• Selective serotonin reuptake inhibitors (SSRIs)
• Tricyclic antidepressant (TCA) and related non-selective reuptake inhibitors
• (NSRIs)
• Treatment for attention deficit hyperactivity disorder (ADHD), narcolespy
• TCA/phenothiazine combinations
• TCA/benzodiazepine combinations
• TCA/non-phenothiazine combinations
• Anticonvulsants
• Anticonvulsants
• TCA/phenothiazine/benzodiazepine combinations
• Alpha-2 receptor antagonist antidepressants
• Serotonin-norepinephrine reuptake inhibitors (SNRIs)
• Norepinephrine dopamine reuptake inhibitors (NDRIs)
• Serotonin agonist and reuptake inhibitors (SARIs)
• MAOIs-non-selective and irreversible
• MAOIs selective and reversible
• MAOIs non-selective and irreversible/phenothiazine combs
• Antidepressant/carbamate anxiolytic combinations
• Treatment for ADHD, norepinephrine reuptake inhibitor (NRI) type
• Hypnotics, melatonin receptor agonists
• Adrenergic, aromatic, non-catecholamine amphetamine preps

Topics: